Cargando…
Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Airway Epithelial Cells
The coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2 coronavirus, is devastatingly impacting human health. A prominent component of COVID-19 is the infection and destruction of the ciliated respiratory cells, which perpetuates dissemination and disrupts protective mucociliary transport...
Autores principales: | Campos-Gomez, Javier, Petty, Courtney Fernandez, Mazur, Marina, Tang, Liping, Solomon, George M., Joseph, Reny, Li, Qian, Lever, Jacelyn E. Peabody, Hussain, Shah, Harrod, Kevin, Onuoha, Ezinwanne, Kim, Harrison, Rowe, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915467/ https://www.ncbi.nlm.nih.gov/pubmed/36778446 http://dx.doi.org/10.1101/2023.01.30.526308 |
Ejemplares similares
-
Mucociliary clearance augmenting drugs block SARS-CoV-2 replication in human airway epithelial cells
por: Campos-Gómez, Javier, et al.
Publicado: (2023) -
Mucociliary Transport Deficiency and Disease Progression in Syrian Hamsters with SARS-CoV-2 Infection
por: Li, Qian, et al.
Publicado: (2022) -
Mucociliary transport deficiency and disease progression in Syrian hamsters with SARS-CoV-2 infection
por: Li, Qian, et al.
Publicado: (2023) -
Airway Epithelial Nucleotide Release Contributes to Mucociliary Clearance
por: van Heusden, Catharina, et al.
Publicado: (2021) -
Regional Differences in Mucociliary Clearance in the Upper and Lower Airways
por: Rogers, Troy D., et al.
Publicado: (2022)